{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T22:05:00Z","timestamp":1787868300413,"version":"build-2784847793"},"reference-count":103,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.seminoncol.2025.152374","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T20:54:04Z","timestamp":1750798444000},"page":"152374","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Recent updates on novel heterocyclic scaffolds of anticancer potential as emerging tubulin inhibitors"],"prefix":"10.1016","volume":"52","author":[{"given":"Sahil","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urvashi","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.seminoncol.2025.152374_bib0001","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jcrpr.2017.07.001","article-title":"Review of cancer from perspective of molecular","volume":"4","author":"Hassanpour","year":"2017","journal-title":"J Cancer Res Pract"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0002","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0003","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ejmech.2018.04.001","article-title":"Therapeutic journery of nitrogen mustard as alkylating anticancer agents: historic to future perspectives","volume":"151","author":"Singh","year":"2018","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0004","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.clinthera.2016.03.026","article-title":"Current challenges in cancer treatment","volume":"38","author":"Zugazagoitia","year":"2016","journal-title":"Clin Ther"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0005","first-page":"2999","article-title":"New anticancer agents: recent developments in tumor therapy","volume":"32","author":"Ali","year":"2012","journal-title":"Anticancer Res"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0006","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejpb.2015.03.018","article-title":"Advanced targeted therapies in cancer: drug nanocarriers, the future of chemotherapy","volume":"93","author":"P\u00e9rez-Herrero","year":"2015","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0007","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23074001","article-title":"A review of the recent developments of molecular hybrids targeting tubulin polymerization","volume":"23","author":"Ebenezer","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0008","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1080\/13543776.2019.1648433","article-title":"Tubulin inhibitors as novel anticancer agents: an overview on patents (2013\u20132018)","volume":"29","author":"Haider","year":"2019","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0009","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/med.21568","article-title":"Current advances of tubulin inhibitors as dual acting small molecules for cancer therapy","volume":"39","author":"Arnst","year":"2019","journal-title":"Med Res Rev"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0010","doi-asserted-by":"crossref","first-page":"7963","DOI":"10.1021\/acs.jmedchem.1c00100","article-title":"Recent progress on tubulin inhibitors with dual targeting capabilities for cancer therapy","volume":"64","author":"Shuai","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0011","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1080\/13543784.2016.1189901","article-title":"Early investigational tubulin inhibitors as novel cancer therapeutics","volume":"25","author":"Nepali","year":"2016","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0012","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1517\/13543776.2014.859247","article-title":"Tubulin inhibitors: a patent review","volume":"24","author":"Liu","year":"2014","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0013","series-title":"Key heterocyclic cores for smart anticancer drug\u2013design, part I","author":"Singh","year":"2022"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0014","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s43094-020-00141-y","article-title":"A brief review of the biological potential of indole derivatives","volume":"6","author":"Kumar","year":"2020","journal-title":"Futur J Pharm Sci"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103021","article-title":"Medicinal chemistry of indole derivatives: current to future therapeutic prospectives","volume":"89","author":"Kumari","year":"2019","journal-title":"Bioorg Chem"},{"issue":"7","key":"10.1016\/j.seminoncol.2025.152374_bib0016","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1016\/j.apsb.2022.03.021","article-title":"Target-based anticancer indole derivatives and insight into structure\u2013activity relationship: a mechanistic review update (2018\u20132021)","volume":"12","author":"Dhiman","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116597","article-title":"Indole derivatives as tubulin polymerization inhibitors for the development of promising anticancer agents","volume":"55","author":"Hong","year":"2022","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0018","first-page":"46","article-title":"Discovery of new indole-based 1,2,4-triazole derivatives as potent tubulin polymerization inhibitors with anticancer activity","author":"Yang","year":"2021","journal-title":"New J Chem"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0019","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ejmech.2018.04.042","article-title":"New 6- and 7-heterocyclyl-1H-indole derivatives as potent tubulin assembly and cancer cell growth inhibitors","volume":"152","author":"La Regina","year":"2018","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0020","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1039\/C7MD00450H","article-title":"New (3-(1H-benzo[d]imidazol-2-yl))\/(3-(3H-imidazo[4,5-b] pyridin-2- yl))-(1H-indol-5-yl)(3,4,5-trimethoxyphenyl)methanone conjugates as tubulin polymerization inhibitors","volume":"9","author":"Mullagiri","year":"2018","journal-title":"Medchemcomm"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0021","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.ejmech.2016.09.056","article-title":"Design, synthesis, and biological evaluation of cyclic-indole derivatives as anti-tumor agents via the inhibition of tubulin polymerization","volume":"125","author":"Yan","year":"2017","journal-title":"Eur J Med Chem"},{"issue":"5","key":"10.1016\/j.seminoncol.2025.152374_bib0022","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202400817","article-title":"New indole-based phenylthiazolyl-2,4-dihydropyrazolones as tubulin polymerization inhibitors: multicomponent synthesis, cytotoxicity evaluation, and in silico studies","volume":"20","author":"Bakchi","year":"2025","journal-title":"ChemMedChem"},{"issue":"7","key":"10.1016\/j.seminoncol.2025.152374_bib0023","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1039\/D4MD00210E","article-title":"Synthesis, in silico, in vitro evaluation of furanyl- and thiophenyl-3-phenyl-1H-indole-2-carbohydrazide derivatives as tubulin inhibitors and anticancer agents","volume":"15","author":"Saruengkhanphasit","year":"2024","journal-title":"RSC Med Chem"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115794","article-title":"Synthesis and biological evaluation of structurally diverse 6-aryl-3-aroyl-indole analogues as inhibitors of tubulin polymerization","volume":"263","author":"Ren","year":"2024","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0025","article-title":"Discovery of novel thienopyridine indole derivatives as inhibitors of tubulin polymerization targeting the colchicine-binding site with potent anticancer activities","author":"Liu","year":"2025","journal-title":"Eur J Med Chem"},{"issue":"20","key":"10.1016\/j.seminoncol.2025.152374_bib0026","doi-asserted-by":"crossref","first-page":"7414","DOI":"10.1021\/jm100884b","article-title":"Discovery of novel 2-aryl-4-benzoyl-imidazoles targeting the colchicines binding site in Tubulin As potential anticancer agents","volume":"53","author":"Chen","year":"2010","journal-title":"J Med Chem"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104904","article-title":"Design, synthesis and biological evaluation of novel imidazole-chalcone derivatives as potential anticancer agents and tubulin polymerization inhibitors","volume":"112","author":"Rahimzadeh Oskuei","year":"2021","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113826","article-title":"Design, synthesis and bioevaluation of 6-aryl-1-(3,4,5-trimethoxyphenyl)-1H-benzo[d]imidazoles as tubulin polymerization inhibitors","volume":"226","author":"Liu","year":"2021","journal-title":"Eur J Med Chem"},{"issue":"9","key":"10.1016\/j.seminoncol.2025.152374_bib0029","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1021\/acsmedchemlett.3c00298","article-title":"Fused imidazopyrazine-based tubulin polymerization inhibitors inhibit neuroblastoma cell function","volume":"14","author":"Thammathong","year":"2023","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2022.117098","article-title":"Design, synthesis, and bioevaluation of imidazo [1, 2\u2013a] pyrazine derivatives as tubulin polymerization inhibitors with potent anticancer activities","volume":"76","author":"Deng","year":"2022","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112847","article-title":"Development of triazolothiadiazine derivatives as highly potent tubulin polymerization inhibitors: structure-activity relationship, in vitro and in vivo study","volume":"208","author":"Ma","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0032","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1007\/s11030-021-10258-8","article-title":"Discovery of (\u00b1)-3-(1H-pyrazol-1-yl)-6,7-dihydro-5H- [1,2,4] triazolo[3,4-b] [1,3,4] thiadiazine derivatives with promising in vitro anticoronavirus and antitumoral activity","volume":"26","author":"Jilloju","year":"2022","journal-title":"Mol Divers"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0033","article-title":"Design, synthesis and structure-activity relationship of 3,6-diaryl-7H- [1,2,4] triazolo [3,4-b] [1,3,4] thiadiazines as novel tubulin inhibitors","volume":"7","author":"Xu","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0034","first-page":"38","article-title":"Synthesis, biological evaluation, and structure-activity relationships of new tubulin polymerization inhibitors based on 5-amino-1,2,4-triazole scaffold","author":"Yang","year":"2021","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0035","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1134\/S1068162023050047","article-title":"Imidazole-thiazolidine-2, 4-dione conjugated 1, 2, 3-triazole derivatives as tubulin aiming antiproliferative agents","volume":"49.5","author":"Nagaraju","year":"2023","journal-title":"Russian J Bioorgan Chem"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.116118","article-title":"Design, synthesis and biological evaluation of 1, 2, 3-triazole benzothiazole derivatives as tubulin polymerization inhibitors with potent anti-esophageal cancer activities","volume":"265","author":"Wu","year":"2024","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104141","article-title":"Design, synthesis, molecular modeling, and biological evaluation of pyrazole-naphthalene derivatives as potential anticancer agents on MCF-7 breast cancer cells by inhibiting tubulin polymerization","volume":"103","author":"Wang","year":"2020","journal-title":"Bioorg Chem"},{"issue":"2","key":"10.1016\/j.seminoncol.2025.152374_bib0038","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24020279","article-title":"Synthesis of novel pyrazole derivatives and their tumor cell growth inhibitory activity","volume":"24","author":"Cui","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0039","doi-asserted-by":"crossref","first-page":"7993","DOI":"10.1039\/C4OB01152J","article-title":"Pyrazole-oxadiazole conjugates: synthesis, antiproliferative activity and inhibition of tubulin polymerization","volume":"12","author":"Kamal","year":"2014","journal-title":"Org Biomol Chem"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0040","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1021\/acsomega.7b01784","article-title":"Drug-clinical agent molecular hybrid: synthesis of diaryl(trifluoromethyl)pyrazoles as tubulin targeting anticancer agents","volume":"3","author":"Hura","year":"2018","journal-title":"ACS Omega"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0041","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ejmech.2013.10.077","article-title":"Design and synthesis of pyrazole-oxindole conjugates targeting tubulin polymerization as new anticancer agents","volume":"92","author":"Kamal","year":"2015","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0042","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/ddr.22016","article-title":"Discovery of pyrazole-carbohydrazide with indole moiety as tubulin polymerization inhibitors and anti-tumor candidates","volume":"84.1","author":"Man","year":"2023","journal-title":"Drug Develop Res"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0043","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1016\/j.bmcl.2014.07.035","article-title":"New benzimidazole-2-urea derivatives as tubulin inhibitors","volume":"24","author":"Wang","year":"2014","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113826","article-title":"Design, synthesis and bioevaluation of 6-aryl-1-(3,4,5-trimethoxyphenyl)-1H-benzo[d]imidazoles as tubulin polymerization inhibitors","volume":"226","author":"Liu","year":"2021","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0045","doi-asserted-by":"crossref","first-page":"4498","DOI":"10.1021\/acs.jmedchem.0c01837","article-title":"Discovery of novel benzimidazole and indazole analogues as tubulin polymerization inhibitors with potent anticancer activities","volume":"64","author":"Ren","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0046","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2023.129494","article-title":"Benzimidazole derivatives as tubulin polymerization inhibitors: design, synthesis and in vitro cytotoxicity studies","volume":"96","author":"Laxmikeshav","year":"2023","journal-title":"Bioorg Med Chemistry Letters"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0047","doi-asserted-by":"crossref","first-page":"13169","DOI":"10.1039\/D3RA01927F","article-title":"CuI-mediated synthesis of 1-aryl-5, 6, 7-trimethoxybenzimidazoles as potent antitubulin agents","volume":"13.19","author":"Peng","year":"2023","journal-title":"RSC Adv"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0048","first-page":"38","article-title":"Discovery of novel arylamide derivatives containing piperazine moiety as inhibitors of tubulin polymerisation with potent liver cancer inhibitory activity","author":"Shi","year":"2023","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0049","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1074\/jbc.M113.499319","article-title":"Novel piperazine-based compounds inhibit microtubule dynamics and sensitize colon cancer cells to tumor necrosis factor-induced apoptosis","volume":"289","author":"Chopra","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0050","doi-asserted-by":"crossref","first-page":"6184","DOI":"10.1039\/C9OB00558G","article-title":"Synthesis and evaluation of antiproliferative microtubule-destabilising combretastatin A-4 piperazine conjugates","volume":"17","author":"O\u2019Boyle","year":"2019","journal-title":"Org Biomol Chem"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0051","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116497","article-title":"Design, synthesis of combretastatin A-4 piperazine derivatives as potential antitumor agents by inhibiting tubulin polymerization and inducing autophagy in HCT116 cells","volume":"272","author":"Zhang","year":"2024","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0052","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1016\/j.bmcl.2014.07.089","article-title":"Antiproliferative 4-(1,2,4-oxadiazol-5-yl) piperidine-1-carboxamides, a new tubulin inhibitor chemotype","volume":"24","author":"Krasavin","year":"2014","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0053","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1080\/14756366.2020.1783664","article-title":"Novel piperidine derivatives as colchicine binding site inhibitors induce apoptosis and inhibit epithelial-mesenchymal transition against prostate cancer PC3 cells","volume":"35","author":"Fu","year":"2020","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0054","article-title":"Design and synthesis of 1-(4-Bromo-2-(Pyrrolidine-1-Yl) benzyl) piperidine-based derivatives as anti-tubulin agents","author":"Rambabu","year":"2025","journal-title":"Curr Topics Med Chem"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0055","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.ejmech.2006.07.004","article-title":"Synthesis and biological activity of 8-azapurine and pyrazolo[4,3-d] pyrimidine analogues of myoseverin","volume":"41","author":"Kry\u0161tof","year":"2006","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0056","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/med.21568","article-title":"Current advances of tubulin inhibitors as dual acting small molecules for cancer therapy","volume":"39","author":"Arnst","year":"2019","journal-title":"Med Res Rev"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0057","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1111\/cbdd.12616","article-title":"Design, synthesis and molecular docking studies of novel indole-pyrimidine hybrids as tubulin polymerization inhibitors","volume":"86","author":"Hu","year":"2015","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0058","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112519","article-title":"Design, synthesis, and bioevaluation of pyrazolo [1, 5-a] pyrimidine derivatives as tubulin polymerization inhibitors targeting the colchicine binding site with potent anticancer activities","volume":"202","author":"Li","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0059","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2024.1447831","article-title":"Design, synthesis, and bioevaluation of diarylpyrimidine derivatives as novel microtubule destabilizers","volume":"12","author":"Xiu","year":"2024","journal-title":"Frontiers in Chemistry"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0060","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1248\/cpb.c20-00575","article-title":"Design, synthesis and biological evaluation of novel 4-(4-methoxynaphthalen-1-yl)-5-arylpyrimidin-2-amines as tubulin polymerization inhibitors","volume":"68.12","author":"Liu","year":"2020","journal-title":"Chem Pharmaceut Bulletin"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0061","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1021\/acs.jmedchem.9b01815","article-title":"Structure-activity relationship study of novel 6-aryl-2-benzoyl-pyridines as tubulin polymerization inhibitors with potent antiproliferative properties","volume":"63","author":"Chen","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0062","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106032","article-title":"Imidazo[4,5-b] pyridine derived tubulin polymerization inhibitors: design, synthesis, biological activity in vitro and computational analysis","volume":"127","author":"Bo\u010dek","year":"2022","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0063","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1039\/D1MD00392E","article-title":"Sessions RB. Identification and validation of novel microtubule suppressors with an imidazopyridine scaffold through structure-based virtual screening and docking","volume":"13","author":"Elseginy","year":"2022","journal-title":"RSC Med Chem"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0064","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1080\/14756366.2022.2130284","article-title":"Design, synthesis and biological evaluation of novel diarylpyridine derivatives as tubulin polymerisation inhibitors","volume":"37.1","author":"Yang","year":"2022","journal-title":"J Enzyme Inhibit Med Chem"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0065","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.1021\/acs.jmedchem.6b00158","article-title":"Design, synthesis, and evaluation of in vitro and in vivo anticancer activity of 4-substituted coumarins: a novel class of potent tubulin polymerization inhibitors","volume":"59","author":"Cao","year":"2016","journal-title":"J Med Chem"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0066","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104605","article-title":"Ferulin C triggers potent PAK1 and p21-mediated anti-tumor effects in breast cancer by inhibiting tubulin polymerization in vitro and in vivo","volume":"152","author":"Yao","year":"2020","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0067","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114467","article-title":"Discovery of novel coumarin-indole derivatives as tubulin polymerization inhibitors with potent anti-gastric cancer activities","volume":"238","author":"Song","year":"2022","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0068","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.137761","article-title":"Novel tubulin polymerization inhibitors based on the hybridization of coumarin and indole ring: design, synthesis and bioactivities evaluation","volume":"1305","author":"Yang","year":"2024","journal-title":"J Mol Struct"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152374_bib0069","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13065-023-01063-5","article-title":"Novel 8-methoxycoumarin-3-carboxamides with potent anticancer activity against liver cancer via targeting caspase-3\/7 and \u03b2-tubulin polymerization","volume":"17","author":"Alzamami","year":"2023","journal-title":"BMC Chem"},{"issue":"46","key":"10.1016\/j.seminoncol.2025.152374_bib0070","doi-asserted-by":"crossref","first-page":"32547","DOI":"10.1039\/D3RA06644D","article-title":"Design, synthesis and antiproliferative screening of newly synthesized coumarin-acrylamide hybrids as potential cytotoxic and apoptosis-inducing agents","volume":"13","author":"Abd El-Lateef","year":"2023","journal-title":"RSC Adv"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0071","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1231450","article-title":"Natural product-inspired synthesis of coumarin\u2013chalcone hybrids as potential anti-breast cancer agents","volume":"14","author":"Alhakamy","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0072","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejmech.2016.02.069","article-title":"Synthesis and biological evaluation of quinoline analogues of flavones as potential anticancer agents and tubulin polymerization inhibitors","volume":"114","author":"Shobeiri","year":"2016","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0073","doi-asserted-by":"crossref","first-page":"6060","DOI":"10.1016\/j.bmc.2017.09.043","article-title":"3\u2032-Hydroxy-3,4\u2032-dimethoxyflavone blocks tubulin polymerization and is a potent apoptotic inducer in human SK-MEL-1 melanoma cells","volume":"25","author":"Est\u00e9vez-Sarmiento","year":"2017","journal-title":"Bioorg Med Chem"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152374_bib0074","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2023.2276665","article-title":"Flavone-based dual PARP-tubulin inhibitor manifesting efficacy against endometrial cancer","volume":"38","author":"Sharma","year":"2023","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0075","article-title":"Therapeutic role of flavonoids and flavones in cancer prevention: current trends and future perspectives","volume":"3","author":"Khan","year":"2021","journal-title":"Eur J Med Chem Reports"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0076","doi-asserted-by":"crossref","first-page":"7385","DOI":"10.1038\/s41598-025-91772-9","article-title":"Synthesis, physicochemical characterization and biological activity of novel pyrrole flavones","volume":"15.1","author":"Sysak","year":"2025","journal-title":"Scient Rep"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0077","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112448","article-title":"Design, synthesis, in vitro and in vivo biological evaluation of 2-amino-3-aroylbenzo[b]furan derivatives as highly potent tubulin polymerization inhibitors","volume":"200","author":"Oliva","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0078","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.4155\/fmc-2018-0036","article-title":"Design and synthesis of novel 5-(4-chlorophenyl) furan derivatives with inhibitory activity on tubulin polymerization","volume":"10","author":"Moussa","year":"2018","journal-title":"Future Med Chem"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0079","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/cmdc.201300366","article-title":"Synthesis and biological evaluation of benzo[b]furans as inhibitors of tubulin polymerization and inducers of apoptosis","volume":"9","author":"Kamal","year":"2014","journal-title":"ChemMedChem"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112105","article-title":"Synthesis and biological evaluation of novel shikonin-benzo[b]furan derivatives as tubulin polymerization inhibitors targeting the colchicine binding site","volume":"190","author":"Shao","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0081","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2023.129347","article-title":"Synthesis, modeling, and biological evaluation of anti-tubulin indole-substituted furanones","volume":"90","author":"Hurysz","year":"2023","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0082","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.3390\/molecules27082606","article-title":"Design and synthesis of some new furan-based derivatives and evaluation of in vitro cytotoxic activity","volume":"27.8","author":"Bukhari","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0083","article-title":"Structure-based design and synthesis of novel furan-diketopiperazine-type derivatives as potent microtubule inhibitors for treating cancer","volume":"28.10","author":"Ding","year":"2020","journal-title":"Bioorganic & Medicinal Chemistry"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0084","doi-asserted-by":"crossref","first-page":"33599","DOI":"10.1021\/acsomega.2c05077","article-title":"Synthesis and molecular docking study of new thiazole derivatives as potential tubulin polymerization inhibitors","volume":"7","author":"El-Abd","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bioorg.2017.10.019","article-title":"Synthesis of benzo[d]imidazo [2,1-b] thiazole-chalcone conjugates as microtubule targeting and apoptosis inducing agents","volume":"76","author":"Sultana","year":"2018","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0086","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.132648","article-title":"Synthesis, biological evaluation of novel thiopyrano[2,3-d] thiazoles incorporating arylsulfonate moiety as potential inhibitors of tubulin polymerization, and molecular modeling studies","volume":"1258","author":"Metwally","year":"2022","journal-title":"J Mol Struct"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0087","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.3390\/ph17091154","article-title":"Synthesis of new thiazole-privileged chalcones as tubulin polymerization inhibitors with potential anticancer activities","volume":"17.9","author":"Hashem","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0088","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.ejmech.2017.11.096","article-title":"2-Alkoxycarbonyl-3-arylamino-5-substituted thiophenes as a novel class of antimicrotubule agents: design, synthesis, cell growth and tubulin polymerization inhibition","volume":"143","author":"Romagnoli","year":"2018","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0089","doi-asserted-by":"crossref","first-page":"5041","DOI":"10.1016\/j.bmcl.2008.08.006","article-title":"Synthesis and biological evaluation of 2-amino-3-(3\u2032,4\u2032,5\u2032-trimethoxybenzoyl)-6-substituted-4,5,6,7-tetrahydrothieno[2,3-c] pyridine derivatives as antimitotic agents and inhibitors of tubulin polymerization","volume":"18","author":"Romagnoli","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0090","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1021\/jm400043d","article-title":"Synthesis and biological evaluation of 2-(Alkoxycarbonyl)-3-anilinobenzo[b]thiophenes and thieno[2,3-b] pyridines as new potent anticancer agents","volume":"56","author":"Romagnoli","year":"2013","journal-title":"J Med Chem"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0091","article-title":"Exploring the potential of thiophene derivatives as dual inhibitors of \u03b2-tubulin and wnt\/\u03b2-catenin pathways for gastrointestinal cancers in vitro","volume":"10.11","author":"Fu","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0092","article-title":"Thiophene derivative-loaded nanoparticles mediate anticancer activity through the inhibition of kinases and microtubule assembly","volume":"4.7","author":"Abdel-Rahman","year":"2021","journal-title":"Adv Therapeut"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0093","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116791","article-title":"Discovery of novel thiophene [3, 2-d] pyrimidine-based tubulin inhibitors with enhanced antitumor efficacy for combined use with anti-pd-l1 immunotherapy in melanoma","volume":"277","author":"Xu","year":"2024","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0094","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1080\/14756366.2021.1917564","article-title":"Tertiary sulphonamide derivatives as dual acting small molecules that inhibit LSD1 and suppress tubulin polymerisation against liver cancer","volume":"36","author":"Ding","year":"2021","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0095","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1080\/14756366.2021.1943378","article-title":"Synthesis, biological evaluation and molecular docking investigation of new sulphonamide derivatives bearing naphthalene moiety as potent tubulin polymerisation inhibitors","volume":"36","author":"Wang","year":"2021","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0096","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.3390\/molecules22091470","article-title":"Design and antiproliferative evaluation of novel sulfanilamide derivatives as potential tubulin polymerization inhibitors","volume":"22.9","author":"Fu","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0097","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1021\/acsmedchemlett.1c00219","article-title":"Design, synthesis, and biological evaluation of novel 1, 3-oxazole sulfonamides as tubulin polymerization inhibitors","volume":"12.6","author":"Sisco","year":"2021","journal-title":"ACS Med Chem Letters"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0098","doi-asserted-by":"crossref","first-page":"5765","DOI":"10.1016\/j.arabjc.2020.04.014","article-title":"Design, synthesis and biological evaluation of isoxazole-naphthalene derivatives as anti-tubulin agents","volume":"13","author":"Wang","year":"2020","journal-title":"Arab J Chem"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0099","doi-asserted-by":"crossref","first-page":"5290","DOI":"10.1016\/j.bmc.2017.07.048","article-title":"Constructing novel dihydrofuran and dihydroisoxazole analogues of isocombretastatin-4 as tubulin polymerization inhibitors through [3+2] reactions","volume":"25","author":"Song","year":"2017","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0100","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.ejmech.2014.11.063","article-title":"Synthesis and structure\u2013activity relationships of pyridinyl-1H-1,2,3-triazolyldihydroisoxazoles as potent inhibitors of tubulin polymerization","volume":"90","author":"Suman","year":"2015","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0101","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/cmdc.201100511","article-title":"3-Substituted 2-phenylimidazo[2,1-b] benzothiazoles: synthesis, anticancer activity, and inhibition of tubulin polymerization","volume":"7","author":"Kamal","year":"2012","journal-title":"ChemMedChem"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0102","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/jhet.3427","article-title":"Design, synthesis, and biological evaluation of 2-(4- Aminophenyl) benzothiazole analogues as antiproliferative agents","volume":"56","author":"Narva","year":"2019","journal-title":"J Heterocycl Chem"},{"key":"10.1016\/j.seminoncol.2025.152374_bib0103","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1080\/14756366.2020.1753721","article-title":"Antiproliferative benzothiazoles incorporating a trimethoxyphenyl scaffold as novel colchicine site tubulin polymerisation inhibitors","volume":"35.1","author":"Fu","year":"2020","journal-title":"J Enzyme Inhibit Med Chem"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775425000661?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775425000661?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T21:20:33Z","timestamp":1750800033000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775425000661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":103,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0093775425000661"],"URL":"https:\/\/doi.org\/10.1016\/j.seminoncol.2025.152374","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent updates on novel heterocyclic scaffolds of anticancer potential as emerging tubulin inhibitors","name":"articletitle","label":"Article Title"},{"value":"Seminars in Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seminoncol.2025.152374","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152374"}}